Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Underdog Pharmaceuticals logo — Pioneering solutions that address the root causes of age-rel...

Underdog Pharmaceuticals

Pioneering solutions that address the root causes of age-related diseases through targeted intervention and innovative molecular design.

Founded 2019 Seed Total: $17.52M Pharmaceutical

General Information

Company Name Underdog Pharmaceuticals
Founded Year 2019
Founders / Decision Makers
Team member
Industries Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Underdog Pharmaceuticals. To contact Underdog Pharmaceuticals, visit underdogpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Underdog Pharmaceuticals compare?

A PDF of Underdog Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Underdog Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Underdog Pharmaceuticals

Underdog Pharmaceuticals is a pharmaceutical startup founded in 2019. The company's slogan emphasizes its focus on pioneering solutions that address the root causes of age-related diseases through targeted intervention and innovative molecular design. Underdog Pharmaceuticals is dedicated to developing straightforward solutions targeting harmful forms of cholesterol through the use of intelligently designed molecules. This pioneering approach aims to offer the first genuinely effective treatments for conditions such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. The company's products are based on innovative derivatives of a well-known, safe compound and are informed by a fresh perspective on cardiovascular disease emerging from a SENS Research Foundation initiative. The latest development for Underdog Pharmaceuticals is a significant milestone, as the company secured a $10.00M Seed Round investment on 23 September 2021 from Kizoo Technology Capital. This injection of capital is expected to drive the company's research and development efforts towards bringing their innovative treatments to market.

Business keywords: age-related diseases, molecular design, cardiovascular disease, innovation, intervention, hypercholesterolemia, macular degeneration, SENS Research Foundation, disease-modifying treatments

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $10.00M 1
Kizoo Technology Capital
Kizoo Technology Capital
23 Sep 2021
Venture Round $3.52M -
07 Sep 2021
Seed Round $4.00M 4
Formic Ventures Kizoo Technology Capital
Formic Ventures, Kizoo Technology Capital +2
20 Nov 2019

Underdog Pharmaceuticals Alternatives & Competitors

View All Alternatives
Underdog Pharmaceuticals vs
Inotek Pharmaceuticals
Inotek Pharmaceuticals

Innovative molecules addressing critical eye diseases for millions.

Venture round
Biotechnology, Health Care
Underdog Pharmaceuticals vs
Alkeus Pharmaceuticals, Inc.
Alkeus Pharmaceuticals, Inc.

Transformation in Sight

Series B
58 employees
Biotechnology, Medical Devices
Underdog Pharmaceuticals vs
Adverum Biotechnologies
Adverum Biotechnologies United States

We are on a global mission to establish gene therapy as a new standard of care for the leading cause...

Acquired
133 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About Underdog Pharmaceuticals

Pioneering solutions that address the root causes of age-related diseases through targeted intervention and innovative molecular design.
Underdog Pharmaceuticals was founded in 2019.
Underdog Pharmaceuticals operates in Pharmaceutical. Its work centres on age-related diseases, molecular design, cardiovascular disease and innovation.
Underdog Pharmaceuticals has completed 3 funding rounds, raising a total of $17.52M. The latest funding stage is Seed.
Top alternatives and competitors to Underdog Pharmaceuticals include Inotek Pharmaceuticals, Alkeus Pharmaceuticals, Inc., Adverum Biotechnologies, OliX Pharmaceuticals, Inc., ONL Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Underdog Pharmaceuticals and Inotek Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Underdog Pharmaceuticals, https://bouncewatch.com/company/underdog-pharmaceuticals, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout